Search research articles
Contact Us
Filters
Showing results (391-400 of 401) with videos related to
Page
of 41
Sort By:
Nature Genetics
|
May 27, 2014
Identification of recurrent SMO and BRAF mutations in ameloblastomas
Robert T Sweeney, Andrew C McClary, Benjamin R Myers, et al.
Plos Medicine
|
December 30, 2006
A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies
David S Shames, Luc Girard, Boning Gao, et al.
Gene & Protein in Disease
|
August 1, 2025
Exploring dopamine as the master regulator of brain circuitry and mental health genome
Kenneth Blum, Eric R Braverman, Alireza Sharafshah, et al.
Journal of Pain and Symptom Management
|
June 28, 2022
Admission Code Status and End-of-life Care for Hospitalized Patients With COVID-19
Whitney A Kiker, Si Cheng, Lauren R Pollack, et al.
The Prostate
|
June 22, 2016
Loss of Expression of AZGP1 Is Associated With Worse Clinical Outcomes in a Multi-Institutional Radical Prostatectomy Cohort
James D Brooks, Wei Wei, Jonathan R Pollack, et al.
Annals of the American Thoracic Society
|
April 12, 2017
Refining Low Physical Activity Measurement Improves Frailty Assessment in Advanced Lung Disease and Survivors of Critical Illness
Matthew R Baldwin, Jonathan P Singer, Debbie Huang, et al.
Journal of Translational Medicine
|
April 24, 2024
AZGP1 deficiency promotes angiogenesis in prostate cancer
Ru M Wen, Zhengyuan Qiu, G Edward W Marti, et al.
Open Journal of Immunology
|
November 7, 2024
The First Pilot Epigenetic Type Improvement of Neuropsychiatric Symptoms in a Polymorphic Dopamine D2 (-DRD2/ANKK (Taq1A)), OPRM1 (A/G), DRD3 (C/T), and MAOA (4R) Compromised Preadolescence Male with Putative PANDAS/CANS: Positive Clinical Outcome with Precision-Guided DNA Testing and Pro-Dopamine Regulation (KB220) and Antibacterial Therapies
Kenneth Blum, Igor Elman, David Han, et al.
Current Neuropharmacology
|
January 27, 2025
In Silico Pharmacogenomic Assessment of Glucagon-like Peptide-1 (GLP1) Agonists and the Genetic Addiction Risk Score (GARS) Related Pathways: Implications for Suicide Ideation and Substance Use Disorder
Alireza Sharafshah, Kai-Uwe Lewandrowski, Mark S Gold, et al.
Journal of Medicinal Chemistry
|
February 22, 2024
Structure Guided Discovery of Novel Pan Metallo-β-Lactamase Inhibitors with Improved Gram-Negative Bacterial Cell Penetration
Shuzhi Dong, Zhiqiang Zhao, Haiqun Tang, et al.
Page
of 41
Search research articles
Search
Showing results (391-400 of 401) with videos related to
Sort By:
Page
of 41
Nature Genetics
|
May 27, 2014
Identification of recurrent SMO and BRAF mutations in ameloblastomas
Robert T Sweeney, Andrew C McClary, Benjamin R Myers, et al.
Plos Medicine
|
December 30, 2006
A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies
David S Shames, Luc Girard, Boning Gao, et al.
Gene & Protein in Disease
|
August 1, 2025
Exploring dopamine as the master regulator of brain circuitry and mental health genome
Kenneth Blum, Eric R Braverman, Alireza Sharafshah, et al.
Journal of Pain and Symptom Management
|
June 28, 2022
Admission Code Status and End-of-life Care for Hospitalized Patients With COVID-19
Whitney A Kiker, Si Cheng, Lauren R Pollack, et al.
The Prostate
|
June 22, 2016
Loss of Expression of AZGP1 Is Associated With Worse Clinical Outcomes in a Multi-Institutional Radical Prostatectomy Cohort
James D Brooks, Wei Wei, Jonathan R Pollack, et al.
Annals of the American Thoracic Society
|
April 12, 2017
Refining Low Physical Activity Measurement Improves Frailty Assessment in Advanced Lung Disease and Survivors of Critical Illness
Matthew R Baldwin, Jonathan P Singer, Debbie Huang, et al.
Journal of Translational Medicine
|
April 24, 2024
AZGP1 deficiency promotes angiogenesis in prostate cancer
Ru M Wen, Zhengyuan Qiu, G Edward W Marti, et al.
Open Journal of Immunology
|
November 7, 2024
The First Pilot Epigenetic Type Improvement of Neuropsychiatric Symptoms in a Polymorphic Dopamine D2 (-DRD2/ANKK (Taq1A)), OPRM1 (A/G), DRD3 (C/T), and MAOA (4R) Compromised Preadolescence Male with Putative PANDAS/CANS: Positive Clinical Outcome with Precision-Guided DNA Testing and Pro-Dopamine Regulation (KB220) and Antibacterial Therapies
Kenneth Blum, Igor Elman, David Han, et al.
Current Neuropharmacology
|
January 27, 2025
In Silico Pharmacogenomic Assessment of Glucagon-like Peptide-1 (GLP1) Agonists and the Genetic Addiction Risk Score (GARS) Related Pathways: Implications for Suicide Ideation and Substance Use Disorder
Alireza Sharafshah, Kai-Uwe Lewandrowski, Mark S Gold, et al.
Journal of Medicinal Chemistry
|
February 22, 2024
Structure Guided Discovery of Novel Pan Metallo-β-Lactamase Inhibitors with Improved Gram-Negative Bacterial Cell Penetration
Shuzhi Dong, Zhiqiang Zhao, Haiqun Tang, et al.
Page
of 41